Clinical Trial Details


Research Study Summary

The Parkinson's Progression Markers Initiative (PPMI)


You are being invited to take part in this study because you are thought to have early Parkinson disease (PD). In this research study we will collect clinical information, samples of blood, DNA, urine, cerebral spinal fluid, and brain images from subjects with PD and from subjects without PD. This information will be used to help develop biomarkers for PD. Biomarkers are measures that tell something about PD. We are working on biomarkers in PD because they may help to understand how the disease changes over time. Having good biomarkers for PD may also be useful in developing new treatments and may help to improve clinical care in the future. In this study we will test biomarkers that may be related to the way PD changes over time. We will store information about all the tests and samples of the different fluids, such as blood, urine, spinal fluid, and DNA, for future testing.

Patient Inclusion Criteria:

  • Must be age 30 or older.
  • Must have a diagnosis of Parkinson's disease for 2 years or less at time of screening.
  • Subject can not be taking any medications for Parkinson's disease.

Patient Exclusion Criteria: Please contact BSHRI to get details

To Learn more

CW ID:179319
Date Last Changed: July 19, 2013

Clinical Trial Snapshot

Both Male and Female
30 and up
Overall Status
Facility Type


Banner Sun Health Research Institute
10515 W. Santa Fe Drive
Sun City, AZ 85351
Phone: 623-832-6500
Fax: 623-832-6504

View Map

Research Center Information: Banner Sun Health Research Institute

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.